Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids
- PMID: 2849950
Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids
Abstract
The influence of replacing the phenolic hydroxyl by the methoxy group on opioid receptor binding, analgesic and antitussive action was investigated in the corresponding couples morphine-codeine, hydromorphone-hydrocodone and O-desmethyltramadol (L 235)-tramadol. Binding was studied on rat whole brain membranes (without cerebellum) with the radioligands dihydromorphine (mu-site), ethylketocyclazocine (k-site), D-Ala2-D-Leu5-enkephalin (delta-site) and naloxone (no selective binding). Analgesia (tail flick) and antitussive action (NH3-vapour induced cough) was investigated in rats and ED50 values 10 min after i.v. application were calculated to compare efficacy. All free hydroxyl compounds had higher opioid receptor affinities than the corresponding methoxy derivatives and were more active at the mu-site. The methoxy derivatives codeine and tramadol only had low affinities lacking selectivity towards mu-, kappa-, or delta-binding. Hydrocodone in contrast showed strong and mu-selective binding. The hydroxy compounds had higher analgesic activity than the methoxy congeners and analgesia appeared to correlate with mu-binding affinity. Codeine and hydrocodone were weaker antitussives than the corresponding hydroxy compounds, whereas no significant difference was found between O-desmethyltramadol and tramadol. Only in the tramadol group the methoxy substitution increased antitussive potency in relation to analgesic potency.
Similar articles
-
Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.J Pharmacol Exp Ther. 1992 Jan;260(1):275-85. J Pharmacol Exp Ther. 1992. PMID: 1309873
-
Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.J Pharmacol Exp Ther. 1986 Sep;238(3):1039-44. J Pharmacol Exp Ther. 1986. PMID: 3018217
-
Increased analgesic potency of mu agonists after continuous naloxone infusion in rats.J Pharmacol Exp Ther. 1991 Nov;259(2):582-9. J Pharmacol Exp Ther. 1991. PMID: 1658305
-
[Pharmacology of tramadol].Drugs. 1997;53 Suppl 2:18-24. doi: 10.2165/00003495-199700532-00006. Drugs. 1997. PMID: 9190321 Review. French.
-
The pharmacology of tramadol.Drugs. 1994;47 Suppl 1:3-7. doi: 10.2165/00003495-199400471-00003. Drugs. 1994. PMID: 7517823 Review.
Cited by
-
Tramadol, but not its major metabolite (mono-O-demethyl tramadol) depresses compound action potentials in frog sciatic nerves.Br J Pharmacol. 2006 Oct;149(3):319-27. doi: 10.1038/sj.bjp.0706868. Epub 2006 Aug 21. Br J Pharmacol. 2006. PMID: 16921387 Free PMC article.
-
What is the main mechanism of tramadol?Naunyn Schmiedebergs Arch Pharmacol. 2015 Oct;388(10):999-1007. doi: 10.1007/s00210-015-1167-5. Epub 2015 Aug 21. Naunyn Schmiedebergs Arch Pharmacol. 2015. PMID: 26292636 Review.
-
The Behavioral and Neurochemical Changes Induced by Boldenone and/or Tramadol in Adult Male Rats.Neurochem Res. 2023 May;48(5):1320-1333. doi: 10.1007/s11064-022-03827-2. Epub 2022 Nov 30. Neurochem Res. 2023. PMID: 36449200 Free PMC article.
-
Tramadol for the Management of Opioid Withdrawal: A Systematic Review of Randomized Clinical Trials.Cureus. 2020 Jul 11;12(7):e9128. doi: 10.7759/cureus.9128. Cureus. 2020. PMID: 32789069 Free PMC article. Review.
-
Tramadol produces outward currents by activating mu-opioid receptors in adult rat substantia gelatinosa neurones.Br J Pharmacol. 2005 Jul;145(5):602-7. doi: 10.1038/sj.bjp.0706225. Br J Pharmacol. 2005. PMID: 15834442 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials